triumph-1 retatrutide A summary slide of the data presented today by Dr. Ania Jastreboff at #ADA2026 π¨ TRIUMPH-1: Phase 3 Obesity Trial with Retatrutide π¨ Retatrutide π, a once-weekly triple hormone receptor Retatrutide triumph 1 results 2026
Description
A systematic review of weight loss maintenance interventions found that retention of lean body mass was the strongest predictor of sustained weight loss at 2 and 5-year follow-ups
& Quick, J
American Psychological Association
Add physician monitoring to those two habits and you have a real plan
The results, which appear March 18 in BMJ Medicine, show that the consequences of stopping GLP-1 drugs go beyond weight regain, extending to increased cardiovascular risk, and underscore the importance of continuous treatment for sustained heart protection
